Latest / Equity Mates Investing Podcast
Uncovered: Emyria - Bringing psychedelic-assisted therapies to Australia
Uncovered is our series where we take a closer look at some of the Aussie companies that get less analyst coverage and media attention. And today’s episode is a cracker.
We speak to Dr Michael Winlo, CEO and Managing Director of Emyria (ASX: EMD) about the recent rescheduling of MDMA and psilocybin and his company’s efforts to introduce psychedelic-assisted therapy into Australia.
Want more? Read our write up on Emyria.
Want to ask a question or join us on the podcast, hit us up via our website.
—------
Want to keep learning? Check out the Rask + Equity Mates investing courses.
We’ve worked…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.